Skip to content
ApplyGive

Other ways to search: Events Calendar | UTHSC News

Recent Publications

Racial and Cardiovascular Risk Anomalies in CKD (RCAV) cohort

  1. Constipation and risk of death and cardiovascular events.
    Sumida K, Molnar MZ, Potukuchi PK, Thomas F, Lu JL, Yamagata K, Kalantar-Zadeh K, Kovesdy CP. Atherosclerosis. 2019 Feb;281:114-120. doi: 10.1016/j.atherosclerosis.2018.12.021. Epub 2018 Dec 23. PMID: 30658186

Therapeutic Interventions in Chronic Kidney Disease (TRI-CKD) study

  1. Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD.
    2. Jain N, Johnson LR, Jadvani D, Shrestha P, Kovesdy CP. Kidney360. 2025 Jul 21. doi: 10.34067/KID.0000000918. Online ahead of print. PMID: 40690307
  1. Trends in Opioid Prescriptions and Short-term Mortality Outcomes for Patients With Chronic Kidney Disease and Chronic Pain.
    Surbhi S, Mallisetty Y, Shrestha P, Sumida K, Thomas F, Kalantar-Zadeh K, Kovesdy CP. Mayo Clin Proc. 2025 Jul;100(7):1248-1251. doi: 10.1016/j.mayocp.2025.03.028. PMID: 40610111

  1. Comparative Effectiveness of Lubiprostone and Stool Softeners on Risk of Kidney Outcomes in Patients with CKD.
    Sumida K, Mallisetty Y, Shrestha P, Vo A, Khan RN, Thomas F, Kalantar-Zadeh K, Kovesdy CP. Clin J Am Soc Nephrol. 2025 Jul 1. doi: 10.2215/CJN.0000000779. Online ahead of print. PMID: 40591438

  1. The Association of Antiemetics Use With Incident Chronic Kidney Disease.
    Kalantar DS, Takahashi R, Shen JI, Tran D, Ismail A, Pena EL, Abichequer-Beer M, Thomas F, Lu JL, Sumida K, Kalantar-Zadeh K, Kovesdy CP, Rhee CM. J Ren Nutr. 2025 Jun 28:S1051-2276(25)00128-1. doi: 10.1053/j.jrn.2025.06.004. Online ahead of print. PMID: 40588048

  1. The Association of Fibrate Use with Kidney Outcomes and Mortality.
    Takahashi R, Shen J, Tran D, Elali I, Dai T, Shah A, Dukkipati R, Ismail A, Sumida K, Thomas F, Rhee CM, Kovesdy CP, Kalantar-Zadeh K. Clin J Am Soc Nephrol. 2025 Apr 7;20(6):779-787. doi: 10.2215/CJN.0000000683. PMID: 40193201

  1. The Association of Niacin Use with Kidney Outcomes and Mortality.
    Takahashi R, Bui TA, Elali I, Tran D, Sumida K, Thomas F, Dukkipati R, Shah A, Rhee CM, Kovesdy CP, Kalantar-Zadeh K, Takahashi R. Am J Nephrol. 2025;56(4):457-467. doi: 10.1159/000543098. Epub 2025 Jan 27. PMID: 39870055

  1. Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study.
    Narasaki Y, Kovesdy CP, You AS, Sumida K, Mallisetty Y, Surbhi S, Thomas F, Amin AN, Streja E, Kalantar-Zadeh K, Rhee CM. Lancet Reg Health Am. 2024 Jun 18;36:100814. doi: 10.1016/j.lana.2024.100814. eCollection 2024 Aug. PMID: 38993538

  2. Incident Diuretic Use and Subsequent Risk of Bone Fractures: A Large Nationwide Observational Study of US Veterans.
    Sumida K, Shrestha P, Mallisetty Y, Surbhi S, Thomas F, Streja E, Kalantar-Zadeh K, Kovesdy CP.
    Mayo Clin Proc. 2024 Jun;99(6):913-926. doi: 10.1016/j.mayocp.2023.09.018. Epub 2024 Apr 4.
    PMID: 38573302

  3. Anti-Tumor Necrosis Factor Therapy and Risk of Kidney Function Decline and Mortality in Inflammatory Bowel Disease.
    Sumida K, Shrestha P, Mallisetty Y, Thomas F, Gyamlani G, Streja E, Kalantar-Zadeh K, Kovesdy CP.
    JAMA Netw Open. 2024 Apr 1;7(4):e246822. doi: 10.1001/jamanetworkopen.2024.6822.
    PMID: 38625700

  4. Association of iron therapy with incidence of chronic kidney disease.
    Shrestha P, Paul S, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP.
    Eur J Haematol. 2023 Dec;111(6):872-880. doi: 10.1111/ejh.14091. Epub 2023 Sep 5.
    PMID: 37668586

  5. Association of long-term aspirin use with kidney disease progression.
    Lu JL, Shrestha P, Streja E, Kalantar-Zadeh K, Kovesdy CP.
    Front Med (Lausanne). 2023 Dec 4;10:1283385. doi: 10.3389/fmed.2023.1283385. eCollection 2023.
    PMID: 38111701

  6. Association of oral iron replacement therapy with kidney failure and mortality in CKD patients.
    Paul S, Shrestha P, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP. 
    Clin Kidney J. 2023 Aug 9;16(11):2082-2090.

  7. Therapeutic Interventions in Chronic Kidney Disease (TRI-CKD) study
    Association of oral iron replacement therapy with kidney failure and mortality in CKD patients.
    Paul S, Shrestha P, Sumida K, Thomas F, Surbhi S, Naser AM, Streja E, Rhee CM, Kalantar-Zadeh K, Kovesdy CP.
    Clin Kidney J. 2023. 

Transition of Care in Chronic Kidney Disease (TC-CKD) cohort

  1. Declining Serum Albumin With Stable Body Mass Index: A Mortality Indicator in Predialysis Chronic Kidney Disease. Sarav M, Shrestha P, Naseer A, Thomas F, Sumida K, Kalantar-Zadeh K, Kovesdy CP. J Ren Nutr. 2025 May 6:S1051-2276(25)00088-3. doi: 10.1053/j.jrn.2025.04.005. Online ahead of print.
    PMID: 40339729

  2. Change Over Time in Pre-End-Stage Renal Disease 24-Hour Urine Creatinine as Muscle Mass Surrogate and Post-End-Stage Renal Disease Mortality.
    Amin S, Wall BM, Thomas F, Kalantar-Zadeh K, Sumida K, Kovesdy CP.
    J Ren Nutr. 2024 Mar 20:S1051-2276(24)00050-5. doi: 10.1053/j.jrn.2024.03.002. Online ahead of print.
    PMID: 38513825

Chronic Kidney Disease Prognosis Consortium (CKD-PC)

  1. Estimated glomerular filtration rate, albuminuria, and risk of infection: a collaborative meta-analysis of individual participant data.
    Ishigami J, Surapaneni A, Matsushita K, Coresh J, Grams ME, Ballew SH, Sang Y, Stengel B, Ärnlöv J, Bell S, Carrero JJ, Chang AR, Ciemins EL, Haynes R, Ix J, Kotsis F, Lees JS, Pandit K, Rao P, Robinson-Cohen C, Alencar de Pinho N, Sumida K; CKD Prognosis Consortium. EClinicalMedicine. 2025 Jul 31;86:103372. doi: 10.1016/j.eclinm.2025.103372. eCollection 2025 Aug.
    PMID: 40791893

  2. Development and Validation of the American Heart Association's PREVENT Equations. 
    Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, Go AS, Gutierrez OM, Hwang SJ, Jassal SK, Kovesdy CP, Lloyd-Jones DM, Shlipak MG, Palaniappan LP, Sperling L, Virani SS, Tuttle K, Neeland IJ, Chow SL, Rangaswami J, Pencina MJ, Ndumele CE, Coresh J; Chronic Kidney Disease Prognosis Consortium and the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group.
    Circulation. 2024 Feb 6;149(6):430-449. doi: 10.1161/CIRCULATIONAHA.123.067626. Epub 2023 Nov 10.
    PMID: 37947085

  3. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    Writing Group for the CKD Prognosis Consortium; Grams ME, Coresh J, Matsushita K, Ballew SH, Sang Y, Surapaneni A, Alencar de Pinho N, Anderson A, Appel LJ, Ärnlöv J, Azizi F, Bansal N, Bell S, Bilo HJG, Brunskill NJ, Carrero JJ, Chadban S, Chalmers J, Chen J, Ciemins E, Cirillo M, Ebert N, Evans M, Ferreiro A, Fu EL, Fukagawa M, Green JA, Gutierrez OM, Herrington WG, Hwang SJ, Inker LA, Iseki K, Jafar T, Jassal SK, Jha V, Kadota A, Katz R, Köttgen A, Konta T, Kronenberg F, Lee BJ, Lees J, Levin A, Looker HC, Major R, Melzer Cohen C, Mieno M, Miyazaki M, Moranne O, Muraki I, Naimark D, Nitsch D, Oh W, Pena M, Purnell TS, Sabanayagam C, Satoh M, Sawhney S, Schaeffner E, Schöttker B, Shen JI, Shlipak MG, Sinha S, Stengel B, Sumida K, Tonelli M, Valdivielso JM, van Zuilen AD, Visseren FLJ, Wang AY, Wen CP, Wheeler DC, Yatsuya H, Yamagata K, Yang JW, Young A, Zhang H, Zhang L, Levey AS, Gansevoort RT.
    JAMA. 2023 Oct 3;330(13):1266-1277. doi: 10.1001/jama.2023.17002.
    PMID: 37787795

  4. Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.
    Mark PB, Carrero JJ, Matsushita K, Sang Y, Ballew SH, Grams ME, Coresh J, Surapaneni A, Brunskill NJ, Chalmers J, Chan L, Chang AR, Chinnadurai R, Chodick G, Cirillo M, de Zeeuw D, Evans M, Garg AX, Gutierrez OM, Heerspink HJL, Heine GH, Herrington WG, Ishigami J, Kronenberg F, Lee JY, Levin A, Major RW, Marks A, Nadkarni GN, Naimark DMJ, Nowak C, Rahman M, Sabanayagam C, Sarnak M, Sawhney S, Schneider MP, Shalev V, Shin JI, Siddiqui MK, Stempniewicz N, Sumida K, Valdivielso JM, van den Brand J, Yee-Moon Wang A, Wheeler DC, Zhang L, Visseren FLJ, Stengel B.
    Eur Heart J. 2023 Apr 1;44(13):1157-1166. doi: 10.1093/eurheartj/ehac825.
    PMID: 36691956

  5. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts.
    Grams ME, Brunskill NJ, Ballew SH, Sang Y, Coresh J, Matsushita K, Surapaneni A, Bell S, Carrero JJ, Chodick G, Evans M, Heerspink HJL, Inker LA, Iseki K, Kalra PA, Kirchner HL, Lee BJ, Levin A, Major RW, Medcalf J, Nadkarni GN, Naimark DMJ, Ricardo AC, Sawhney S, Sood MM, Staplin N, Stempniewicz N, Stengel B, Sumida K, Traynor JP, van den Brand J, Wen CP, Woodward M, Yang JW, Wang AY, Tangri N.
    J Am Soc Nephrol. 2023 Mar 1;34(3):482-494. doi: 10.1681/ASN.0000000000000050. Epub 2023 Jan 26.
    PMID: 36857500

UT-DaVita Hemodialysis cohort

  1. Circulating Mycobiota Signatures and Cardiovascular Mortality among Patients Undergoing Hemodialysis.
    Sumida K, Mallisetty Y, Chiu CY, Han Z, Mims TS, Chen C, Beach RT, Dojcsak L, Sumida M, Zhao Q, Bajwa A, Peters BM, Seegmiller JC, Karger AB, Stenvinkel P, Datta S, Langston MA, Kovesdy CP, Pierre JF. J Am Soc Nephrol. 2025 Aug 11. doi: 10.1681/ASN.0000000829. Online ahead of print.
    PMID: 40788689

  2. Association of DNA methylation signatures with premature ageing and cardiovascular death in patients with end-stage kidney disease: a pilot epigenome-wide association study.
    Sumida K, Mozhui K, Liang X, Mallisetty Y, Han Z, Kovesdy CP.
    Epigenetics. 2023 Dec;18(1):2214394. doi: 10.1080/15592294.2023.2214394.
    PMID: 37207321 

  3. Circulating microRNA Profiles for Premature Cardiovascular Death in Patients with Kidney Failure with Replacement Therapy.
    Kuscu C, Mallisetty Y, Naik S, Han Z, Berta CJ, Kuscu C, Kovesdy CP, Sumida K.
    J Clin Med. 2023 Jul 30;12(15):5010. doi: 10.3390/jcm12155010.
    PMID: 37568412
Sep 2, 2025